Shareholders Equity: The sum of preferred and common equity items.
Addex Therapeutics Ltd. Sponsored ADR (ADXN) had Shareholders Equity of $4.19M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.18M |
|
-- |
|
-- |
|
$0.61M |
|
$-0.61M |
|
$-1.57M |
|
$-2.18M |
|
$-2.18M |
|
$-2.18M |
|
$-2.18M |
|
$-2.18M |
|
$-2.18M |
|
$-0.61M |
|
$-0.60M |
|
0.99M |
|
0.99M |
|
$-1.53 |
|
$-1.53 |
|
| Balance Sheet Financials | |
$1.52M |
|
$0.00M |
|
$4.56M |
|
$6.07M |
|
$1.56M |
|
-- |
|
$0.32M |
|
$1.88M |
|
$4.19M |
|
$4.19M |
|
|
Shareholders Equity |
$4.19M |
0.99M |
|
| Cash Flow Statement Financials | |
$-0.98M |
|
-- |
|
$0.08M |
|
$2.09M |
|
$1.19M |
|
$-0.90M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-52.08% |
|
-52.08% |
|
-35.97% |
|
-52.08% |
|
$4.22 |
|
$-0.99 |
|
$-0.99 |
|